Phase
Startup
Sorbus Biomedical
Sorbus Biomedical intends to induce a paradigm shift in how cultivated cells can be used in life science research and healthcare. The company develops a novel biotech equipment that radically improves the function of cultivated cells.
CEO and Founder Roger E. Rönn holds a PhD in human stem cell biology (Lund University), and has an extensive international track record in research and cell cultivation. After supplementing his scientific expertise with knowhow in both device prototyping and entrepreneurship, he founded Sorbus with the intention of making an impact to the field of Life Science.
Did you know?
Traditional cell cultivation in the lab exposes the cell to much higher levels of stress than what the cells would normally experience inside the body.
New technologies for next-gen antibody therapeutics
Single Molecule Nanowire Biosensors for Diagnostics
Medicines for acute systemic inflammatory diseases
Cancer immunotherapies based in cell reprogramming
Introducing the fungal based industrial revolution
Automated microscopy image acquisition and analysis
Fighting iron deficiency
Implants of magnesium alloys
Developing future targeted immunotherapies in cancer
Digital service for patients
Ultrasound analysis for stroke risk assessment
Medical device that reduces pain during vein operation
Cloud-based solutions for genomics data
A reusable, user-friendly, and sustainable pregnancy test
Digital assistive device for post-surgical rehabilitation
Develops the first effective treatment for hypothyroidism
Builds gene therapy viral vectors
Early detection of pancreatic cancer
Bio-based vegan coating for fruits and vegetables
Equipment that improves the function of cultivated cells
Medtech solution for preventing pressure ulcers
Effective treatments for brain tumors
A new suturing choice for abdominal wall closure
Converting waste flows into valuable raw materials
Innovative systemic anti-inflammatory treatments
Safer medical needles for prostate biopsy
